PEG-MGF
PEGylated Growth FactorresearchAlso known as: PEGylated Mechano Growth Factor, PEGylated IGF-1Ec, PEG-MGF peptide
A PEGylated version of Mechano Growth Factor with an extended half-life from minutes to hours, allowing systemic distribution and sustained satellite cell activation for muscle growth and repair.
Overview
PEG-MGF is the PEGylated (polyethylene glycol-conjugated) form of Mechano Growth Factor, created to overcome the extremely short half-life of native MGF. The addition of a PEG moiety extends the half-life from minutes to several hours, allowing it to circulate systemically and act on muscle tissue throughout the body rather than just at the injection site. This makes PEG-MGF more practical for users seeking whole-body muscle repair and growth benefits. However, the PEGylation somewhat reduces the peptide's potency at the receptor level compared to native MGF. PEG-MGF is typically used on rest days to provide sustained satellite cell activation, while native MGF is used immediately post-workout for acute signaling.
Mechanism of Action
PEG-MGF shares MGF's mechanism but with systemic distribution: (1) PEG moiety prevents rapid enzymatic degradation, extending circulation time; (2) Activates satellite cells throughout the body's musculature via systemic delivery; (3) Stimulates satellite cell proliferation through distinct receptor interactions from standard IGF-1; (4) Promotes myogenic precursor cell pool expansion; (5) Enhanced distribution allows recovery support across multiple muscle groups simultaneously; (6) Works synergistically when cycled with IGF-1 LR3 (MGF for proliferation, IGF-1 for differentiation).
Molecular Formula
C121H200N42O39 + PEG moiety
Molecular Weight
~5000 g/mol (varies with PEG chain length)
Sequence
MGF 24-amino acid C-terminal peptide conjugated with polyethylene glycol
Dosage Protocols
Dose Range
200mcg – 400mcg
Frequency
2-3 times per week (rest days)
Route
subcutaneous or intramuscular
Cycle Length
4-6 weeks
Best used on rest days for systemic satellite cell activation. Can be combined with native MGF on training days. Subcutaneous injection is sufficient due to extended half-life.
Source: Community protocols
🧮 Personalized Dosage Calculator
💰 Estimated Pricing
Typical Supply
2mg vial
Last Updated
2026-02
PEGylated Mechano Growth Factor. Longer half-life than MGF. Research: $35-70. Systemic vs local effects. Bodybuilding use.
⚠️ Prices are estimates based on publicly available data and may vary significantly by vendor, location, and prescription status. This is not medical or financial advice.
Side Effects
| Effect | Severity |
|---|---|
| Injection site reaction | mild |
| Lethargy | mild |
| Mild hypoglycemia | mild |
Pros & Cons
Extended half-life makes it practical for systemic muscle recovery across all muscle groups
Can be administered subcutaneously rather than requiring site-specific IM injections
Sustained satellite cell activation promotes ongoing repair between workouts
Lower frequency dosing (2-3x/week) is more convenient than daily peptides
PEGylation reduces receptor-level potency compared to native MGF
Less site-specific targeting than native MGF
Limited research data in humans
Quality concerns with PEGylated research peptides — PEG conjugation varies between sources
Research Studies
🩸 Blood Work
No specific bloodwork requirements reported for this peptide. General health panels are always recommended before starting any peptide protocol.
Legal Status
Not FDA-approved. Available as a research chemical. Banned by WADA. Regulated as a research compound.
Readers Also Viewed
Semaglutide
99An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
98A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
Tirzepatide
97A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.
CJC-1295 + Ipamorelin (Combo)
95The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.
Related Peptides
Semaglutide
An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
Tirzepatide
A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.
CJC-1295 + Ipamorelin (Combo)
The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.